Margarita Arango-Lievano, PhD

Margarita Arango-Lievano, PhD has worked in various roles since 2002. Margarita began their career as a PhD student at INSERM, where they studied the effects of transcriptional dysregulations in Huntington's Disease. In 2006, they joined Weill Cornell Medical College as a Post Doctoral Associate, where they led a project to understand the molecular mechanisms of addiction and depression. In 2010, they served as a Scientific Consultant for the 'Lumières' exhibit at the Biennale Internationale du Design St. Etienne. From 2013 to 2018, they worked at IGF, CNRS, Inserm as a Researcher, where they led 3 major research projects and participated in several collaborative projects, and published 8 original publications and 4 reviews and book chapters. Most recently, they joined Olea Medical - Improved Diagnosis for Life in 2018 as a Solution Owner, Clinical Collaborations Manager, and Project Manager. In 2022, they will become Program Director at FeetMe.

Margarita Arango-Lievano, PhD has a comprehensive education history. Margarita began their studies in 1997 at Pierre and Marie Curie University in Cellular Biology and Animal Physiology. In 2001, they earned their Master's degree in Developmental Biology from the same university. Margarita then went on to earn their PhD in Neuroscience from the same university in 2006. Most recently, they completed a Specialized Master in Management of Innovation in the Health Industry from KEDGE Business School in 2018.